Wheeler Bio, CRB announce kickoff of new Oklahoma City manufacturing facility supporting production of life-saving therapies

Contract Development and Manufacturing Organization (CDMO) Wheeler Bio and CRB – a leading global provider of sustainable engineering, architectural, construction and consulting services to the life sciences industry – today announced the start of construction on a GMP drug substance facility that will support innovators seeking agile, small batch manufacturing services for their clinical trial materials (CTM).

Contract Development and Manufacturing Organization (CDMO) Wheeler Bio and CRB – a leading global provider of sustainable engineering, architectural, construction and consulting services to the life sciences industry – today announced the start of construction on a GMP drug substance facility that will support innovators seeking agile, small batch manufacturing services for their clinical trial materials (CTM).

Read more on PRNewsWire.com

Share

Related Posts